![Jason Paragas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Jason Paragas is currently the Chief Executive Officer at DVLP Medicines.
He is also a Director at Probius DX, Inc. and a Venture Partner at Social Impact Capital, Inc. Mr. Paragas holds a doctorate degree from Icahn School of Medicine at Mount Sinai, which he obtained in 2001.
Postes actifs de Jason Paragas
Sociétés | Poste | Début |
---|---|---|
Probius DX, Inc.
![]() Probius DX, Inc. Medical SpecialtiesHealth Technology ProbiusDx, Inc. develops devices that analyses multiple target proteins. The company was founded by Roger T. Howe, Chaitanya Gupta and Emmanuel P. Quevy and is headquartered in El Cerrito, CA. | Directeur/Membre du Conseil | - |
Social Impact Capital, Inc.
![]() Social Impact Capital, Inc. Investment ManagersFinance Social Impact Capital LLC (Social Impact) is a Venture Capital firm founded in 2015 by Sarah Cone. The firm is headquartered in New York. | Private Equity Investor | 01/04/2021 |
Formation de Jason Paragas
Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Probius DX, Inc.
![]() Probius DX, Inc. Medical SpecialtiesHealth Technology ProbiusDx, Inc. develops devices that analyses multiple target proteins. The company was founded by Roger T. Howe, Chaitanya Gupta and Emmanuel P. Quevy and is headquartered in El Cerrito, CA. | Health Technology |
Social Impact Capital, Inc.
![]() Social Impact Capital, Inc. Investment ManagersFinance Social Impact Capital LLC (Social Impact) is a Venture Capital firm founded in 2015 by Sarah Cone. The firm is headquartered in New York. | Finance |